XML 81 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 16 - Share-Based and Other Compensation Programs (Tables)
12 Months Ended
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of outstanding awards and compensation expense recognized for each type of share-based award The following table summarizes awards outstanding and compensation expense recognized for each type of share-based award as of and for the years ended:
 
 
December 31,
($ in thousands)
 
2018
 
2017
 
2016
Share-Based Compensation Programs
 
Liability
Recorded/
Equity
Instruments
Outstanding
 
Compensation
Cost
Recognized (1)
 
Liability
Recorded/
Equity
Instruments
Outstanding
 
Compensation
Cost
Recognized (1)
 
Liability
Recorded/
Equity
Instruments
Outstanding
 
Compensation
Cost
Recognized (1)
Liabilities: RSUs—Cash-Settled
 
$

 
$

 
$

 
$
1

 
$
18

 
$
(718
)
Equity:
 
 
 
 
 
 
 
 
 
 
 
 
RSUsEquity Settled
 
3,763,633

 
16,591

 
3,434,976

 
12,206

 
3,208,454

 
13,285

Non-Qualified Stock Options
 
1,312,791

 
603

 
1,692,743

 
851

 
2,839,738

 
3,286

Phantom Stock
 
234,427

 
2

 
234,302

 
2

 
234,174

 
2

Employee Stock Purchase Plan
 
 
 
453

 
 
 
432

 
 
 
449

Equity
 
 
 
17,649

 
 
 
13,491

 
 
 
17,022

Total all share-based plans
 
 
 
$
17,649

 
 
 
$
13,492

 
 
 
$
16,304

______________________
(1)
For purposes of calculating compensation cost recognized, we generally consider awards effectively vested (and we recognize the full compensation costs) when grantees become retirement eligible.
Schedule of additional information regarding all share-based awards The following table reflects additional information regarding all share-based awards for the years indicated:
 
Year Ended December 31,
(In thousands)
2018
 
2017
 
2016
Total compensation cost recognized
$
17,649

 
$
13,492

 
$
16,304

Less: Costs deferred as acquisition costs
324

 
269

 
206

Stock-based compensation expense
$
17,325

 
$
13,223

 
$
16,098

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Information with regard to RSUs to be settled in stock for the periods indicated is as follows:
 
Number of
Shares
 
Weighted-Average
Grant Date
Fair Value
Unvested, December 31, 2017 (1) 
3,434,976

 
$
12.90

Granted
1,058,045

 
$
15.58

Vested
(258,845
)
 
$
12.61

Forfeited
(470,543
)
 
$
18.07

Unvested, December 31, 2018 (1) 
3,763,633

 
$
13.04

Schedule of valuation assumptions of performance based RSU he following assumptions:
 
2017
 
2016
Expected life
3 years

 
3 years

Risk-free interest rate (1) 
1.6
%
 
0.9
%
Volatility of Radian’s stock (2) 
28.0
%
 
29.7
%
Average volatility of peer companies (3) 
30.6
%
 
38.2
%
Dividend yield
0.06
%
 
0.08
%
Discount rate (4) 
10.7
%
 
10.7
%
______________________
(1)
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant.
(2)
Volatility of Radian’s stock is used in the calculation of the grant date fair value of the portion of the awards based on TSR Measures, as described above. Volatility is determined at the date of grant using the historical share price volatility and the expected life of each award.
(3)
Average volatility of peer companies is used in the calculation of the grant date fair value of the portion of the awards based on the Relative TSR Measure, as described above.
(4)
A discount is applied to executive officer awards to reflect illiquidity during the one-year post-vesting holding period.
Share-based Compensation Arrangement by Share-based Payment Award, Time-Vested Units, Grants in Period [Table Text Block] Information with regard to grants of time-vested RSUs to be settled in common stock is as follows for the periods indicated:
 
Year Ended December 31,
 
 
2018
 
2017 (1)
 
2016 (2)
 
Time-vested RSUs granted to certain executives and non-executive officers
385,962

(1)
372,489

 
180,380

 
Time-vested RSUs granted to non-employee directors
76,763

(3)
68,337

 
356,040

(4)
Total time-vested RSUs granted (5) 
462,725

 
440,826

 
536,420

 
______________________
(1)
The time-vested RSU awards granted in 2018 and 2017 are scheduled to vest in: (i) pro rata installments on each of the first three anniversaries of the grant date or (ii) generally at the end of three years.
(2)
The time-vested RSU awards granted in 2016 generally are subject to three-year cliff vesting.
(3)
The time-vested RSU awards granted in 2018 to non-employee directors generally are subject to one-year cliff vesting.
(4)
Includes 262,694 time-vested awards granted on February 10, 2016 to convert the outstanding fully-vested 2009 and 2010 time-vested RSUs (to be settled in cash) awarded to our non-employee directors into time-vested RSUs to be settled in shares of our common stock on the conversion date (generally defined as a director’s termination of service with us).
(5)
The grant date fair value of time-vested RSUs was calculated based on the closing price of our common stock on the New York Stock Exchange on the date of grant, discounted for the lack of dividends earned over the vesting period, and is recognized as compensation expense over the service period.
Schedule of information with regard to stock options Information with regard to stock options for the periods indicated is as follows:
($ in thousands, except per-share amounts)
Number of
Shares
 
Weighted
Average
Exercise Price
Per Share
 
Weighted
Average
Remaining Contractual Term
 
Aggregate Intrinsic Value (1)
Outstanding, December 31, 2017
1,692,743

 
$
8.16

 
 
 
 
Granted

 
$

 
 
 
 
Exercised
(375,573
)
 
$
3.79

 
 
 
 
Forfeited
(4,379
)
 
$
14.38

 
 
 
 
Expired

 
$

 
 
 
 
Outstanding, December 31, 2018
1,312,791

 
$
9.39

 
4.9
 
$
9,500

Exercisable, December 31, 2018
966,478

 
$
7.91

 
4.0
 
$
8,361

Available for grant, December 31, 2018
7,906,190

 
 
 
 
 
 

______________________
(1)
Based on the market price of $16.36 at December 31, 2018.
Schedule of fully vested share options The following table summarizes additional information concerning stock option activity for the periods indicated:
 
Years Ended December 31,
($ in thousands, except per-share amounts)
2018
 
2017
 
2016
Granted (number of shares)

 

 
342,090

Weighted-average grant date fair value per share (1) 
$

 
$

 
$
9.72

Aggregate intrinsic value of options exercised
$
6,274

 
$
14,389

 
$
1,519

Tax benefit of options exercised
$
1,318

 
$
5,036

 
$
532

Cash received from options exercised
$
1,425

 
$
7,131

 
$
717

______________________
(1)
We use the Monte Carlo valuation model in determining the grant date fair value of stock options issued to executives and non-executives using the assumptions noted in the following table:
 
Year Ended December 31,
 
2016
Derived service period (years)
3.02 - 4.00

Risk-free interest rate (a) 
1.72
%
Volatility (b) 
94.20
%
Dividend yield
0.08
%
______________________
(a)
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant.
(b)
Volatility is determined at the date of grant using historical share price volatility and expected life of each award.
Schedule of valuation assumptions of stock options granted We use the Monte Carlo valuation model in determining the grant date fair value of stock options issued to executives and non-executives using the assumptions noted in the following table:
 
Year Ended December 31,
 
2016
Derived service period (years)
3.02 - 4.00

Risk-free interest rate (a) 
1.72
%
Volatility (b) 
94.20
%
Dividend yield
0.08
%
______________________
(a)
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant.
(b)
Volatility is determined at the date of grant using historical share price volatility and expected life of each award.
Schedule of outstanding and exercisable options The following table summarizes information concerning outstanding and exercisable options at December 31, 2018:
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
Number
Outstanding
 
Weighted Average
Remaining
Contractual Life
(Years)
 
Weighted Average
Exercise Price
 
Number
Exercisable
 
Weighted Average
Exercise Price
$2.45 - $3.58
565,317

 
3.4
 
$
2.45

 
565,317

 
$
2.45

$5.76 - $7.06

 
0.0
 
$

 

 
$

$10.42 - $15.44
578,612

 
6.0
 
$
13.53

 
306,611

 
$
14.74

$18.42
168,862

 
6.3
 
$
18.42

 
20,000

 
$
18.42

 
1,312,791

 
4.9
 
$
9.39

 
891,928

 
$
7.03

Schedule of valuation assumptions of ESPP The following assumptions were used in our calculation of Employee Stock Purchase Plan compensation expense during 2018:
 
January 1, 2018
 
July 1, 2018
Expected life
6 months

 
6 months

Risk-free interest rate
1.76
%
 
2.43
%
Volatility
31.49
%
 
32.80
%
Dividend yield
0.05
%
 
0.06
%